Volume 2 Issue 3 - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Choice Matters: Diminishing Options as a Result of Industry Consolidation Place New Pressure on Customer Decision-making

Volume 2 Issue 3

Choice Matters: Diminishing Options as a Result of Industry Consolidation Place New Pressure on Customer Decision-making

Soaring merger & acquisition activity in life sciences threatens competition and reduces customer options, both to patients and to pharma and biotech firms seekin...

13 November 2019 Volume 2 Issue 3

Continue Reading →

IDMP: Back on Track and Bearing Down with New Urgency – What Next?

Volume 2 Issue 3

IDMP: Back on Track and Bearing Down with New Urgency – What Next?

As EMA renews its focus on ISO IDMP delivery, life sciences organisations targeting European markets must now step up their own measures to ensure they are compliant ...

13 November 2019 Volume 2 Issue 3

Continue Reading →